Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma

Published:2009-10-08 Issue:10 Volume:4 Page:e7334
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Stone Geoffrey W.,Barzee Suzanne,Snarsky Victoria,Santucci Camila,Tran Brian,Langer Robert,Zugates Gregory T.,Anderson Daniel G.,Kornbluth Richard S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference90 articles.

1. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.;GQ Phan;Proc Natl Acad Sci U S A,2003

2. Targeting the effector site with IFN-alphabeta-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors.;AJ Currie;J Immunol,2008

3. CpG motifs in bacterial DNA and their immune effects.;AM Krieg;Annu Rev Immunol,2002

4. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.;AP Vicari;J Exp Med,2002

5. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance.;Y Yang;Nat Immunol,2004

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2;Frontiers in Immunology;2023-01-24

2. Advances in Therapeutic Targeting of the Tumor Necrosis Factor Receptor Superfamily Members for Cancer Immunotherapy;Handbook of Cancer and Immunology;2023

3. Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling;ACS Applied Bio Materials;2021-11-10

4. Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties;The Journal of Immunology;2021-09-22

5. Physiological models for in vivo imaging and targeting the lymphatic system: Nanoparticles and extracellular vesicles;Advanced Drug Delivery Reviews;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3